Cargando…
TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a hereditary skeletal disorder primarily affecting collagen type I structure and function, causing bone fragility and occasionally versatile extraskeletal symptoms. This study expands the spectrum of OI‐causing TAPT1 mutations and links extracellular matrix changes to...
Autores principales: | Etich, Julia, Semler, Oliver, Stevenson, Nicola L, Stephan, Alice, Besio, Roberta, Garibaldi, Nadia, Reintjes, Nadine, Dafinger, Claudia, Liebau, Max Christoph, Baumann, Ulrich, Mörgelin, Matthias, Forlino, Antonella, Stephens, David J, Netzer, Christian, Zaucke, Frank, Rehberg, Mirko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331569/ https://www.ncbi.nlm.nih.gov/pubmed/37292039 http://dx.doi.org/10.15252/emmm.202317528 |
Ejemplares similares
-
Osteogenesis imperfecta—pathophysiology and therapeutic options
por: Etich, Julia, et al.
Publicado: (2020) -
Dissecting the phenotypic variability of osteogenesis imperfecta
por: Garibaldi, Nadia, et al.
Publicado: (2022) -
Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2019) -
Intracellular and Extracellular Markers of Lethality in Osteogenesis Imperfecta: A Quantitative Proteomic Approach
por: Bini, Luca, et al.
Publicado: (2021) -
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion
por: Besio, Roberta, et al.
Publicado: (2018)